专业协会代表关于非格列酮在治疗患有慢性肾病的 2 型糖尿病患者中的地位的专家意见

{"title":"专业协会代表关于非格列酮在治疗患有慢性肾病的 2 型糖尿病患者中的地位的专家意见","authors":"Ondřej Viklický, Vladimír Tesař, Ivan Rychlı́k, Martin Prázný, R. Ryšavá, R. Češka, Martin Haluzík, Petr Ošťádal, Jan Krejčí, Miloš Táborský","doi":"10.36290/vnl.2024.008","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":508539,"journal":{"name":"Vnitřní lékařství","volume":"92 S84","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Expert opinion of representatives of professional societies on the position of finerenone in the treatment of type 2 diabetics with chronic kidney disease\",\"authors\":\"Ondřej Viklický, Vladimír Tesař, Ivan Rychlı́k, Martin Prázný, R. Ryšavá, R. Češka, Martin Haluzík, Petr Ošťádal, Jan Krejčí, Miloš Táborský\",\"doi\":\"10.36290/vnl.2024.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":508539,\"journal\":{\"name\":\"Vnitřní lékařství\",\"volume\":\"92 S84\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vnitřní lékařství\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36290/vnl.2024.008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vnitřní lékařství","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36290/vnl.2024.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}